Journal criticises Vioxx study for omitting three heart attacks
BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7530.1423 (Published 15 December 2005) Cite this as: BMJ 2005;331:1423- Janice Hopkins Tanne
- New York
The New England Journal of Medicine has issued an editorial “statement of concern” about the omission of data in a paper it published. It said that three heart attacks were omitted from a study comparing rofecoxib (Vioxx) with naproxen, under-stating the risks of rofecoxib.
The editorial by the journal's three top editors will appear in print in the 29 December issue but was published online on 8 December (www.nejm.org, doi: 10.1056/NEJMe058314).
It said: “Relevant data on cardiovascular outcomes had been deleted from the VIGOR [Vioxx gastrointestinal outcomes research] manuscript prior to its submission to the journal and… the authors had withheld data on other relevant cardiovascular outcomes. …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.